Amitriptyline hydrochloride and Pulmonary eosinophilia - a phase IV clinical study of FDA data
Pulmonary eosinophilia is reported only by a few people who take Amitriptyline Hydrochloride.
The phase IV clinical study analyzes which people take Amitriptyline hydrochloride and have Pulmonary eosinophilia. It is created by eHealthMe based on reports of 11,507 people who have side effects while taking Amitriptyline hydrochloride from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
11,507 people reported to have side effects when taking Amitriptyline hydrochloride.
Among them, 2 people (0.02%) have Pulmonary eosinophilia.
What is Amitriptyline hydrochloride?
Amitriptyline hydrochloride has active ingredients of amitriptyline hydrochloride. It is often used in migraine. eHealthMe is studying from 14,726 Amitriptyline hydrochloride users for its effectiveness, alternative drugs and more.
What is Pulmonary eosinophilia?
Pulmonary eosinophilia (increase in the number of eosinophiles in the blood causeing lung infection) is found to be associated with 403 drugs and 130 conditions by eHealthMe.
Number of Amitriptyline hydrochloride and Pulmonary eosinophilia reports submitted per year:
Gender of people who have Pulmonary eosinophilia when taking Amitriptyline hydrochloride *:
- female: 100 %
- male: 0.0 %
Age of people who have Pulmonary eosinophilia when taking Amitriptyline hydrochloride *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common side effects people have besides Pulmonary eosinophilia *:
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 100.00%
Common conditions people have *:
- Neuralgia (pain in one or more nerves): 2 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Amitriptyline hydrochloride and have Pulmonary eosinophilia?Check whether Pulmonary eosinophilia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
How severe was Pulmonary eosinophilia and when was it recovered:
Expand to all the drugs that have ingredients of amitriptyline hydrochloride:
Alternative drugs to, pros and cons of Amitriptyline hydrochloride:
- Amitriptyline hydrochloride (14,726 reports)
Common Amitriptyline hydrochloride side effects:
Browse all side effects of Amitriptyline hydrochloride:a b c d e f g h i j k l m n o p q r s t u v w x y z
Pulmonary eosinophilia treatments and more:
- Pulmonary eosinophilia (1,061 reports)
COVID vaccines that are related to Pulmonary eosinophilia:
- Pulmonary eosinophilia in Moderna COVID Vaccine
- Pulmonary eosinophilia in Pfizer BioNTech Covid Vaccine
- Pulmonary eosinophilia in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Pulmonary eosinophilia:
- Pulmonary eosinophilia (403 drugs)
All the conditions that are associated with Pulmonary eosinophilia:
- Pulmonary eosinophilia (130 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amitriptyline hydrochloride (the active ingredients of Amitriptyline hydrochloride) and Amitriptyline hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Copaxone and Premarin drug interaction - 7 seconds ago
- Glimepiride and Agranulocytosis - 16 seconds ago
- Diovan and Nutritional Condition Abnormal - 17 seconds ago
- Apple Cider Vinegar and Bronchitis - 36 seconds ago
- Maxzide and Electrocardiogram T Wave Abnormal - 37 seconds ago
- Toradol and Amitriptyline Hydrochloride drug interaction - 43 seconds ago
- Evekeo vs. Ritalin - 49 seconds ago
- Lamictal and Hectorol drug interaction - 50 seconds ago
- Navelbine and Raloxifene Hydrochloride drug interaction - 54 seconds ago
- Lorazepam and Stress Cardiomyopathy - 55 seconds ago